Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome

The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects of these agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonly used for treatment of renal cell carcinoma,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaucer, Benjamin, Stone, Abriella, Demanes, Augustus, Seibert, Shawn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822822/
https://www.ncbi.nlm.nih.gov/pubmed/29593922
http://dx.doi.org/10.1155/2018/4273231
_version_ 1783301761349451776
author Chaucer, Benjamin
Stone, Abriella
Demanes, Augustus
Seibert, Shawn M.
author_facet Chaucer, Benjamin
Stone, Abriella
Demanes, Augustus
Seibert, Shawn M.
author_sort Chaucer, Benjamin
collection PubMed
description The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects of these agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonly used for treatment of renal cell carcinoma, metastatic melanoma, and metastatic non-small cell lung cancer. While common side effects are known and well documented, encephalitis is documented as an extremely rare side effect. We present the case of an extremely rare side effect to a common chemotherapeutic agent.
format Online
Article
Text
id pubmed-5822822
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-58228222018-03-28 Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome Chaucer, Benjamin Stone, Abriella Demanes, Augustus Seibert, Shawn M. Case Rep Oncol Med Case Report The treatment of cancer is a rapidly evolving field. As more chemotherapeutic agents become available, reporting the side effects of these agents in clinical practice becomes increasingly important. Nivolumab is one of the chemotherapeutic agents commonly used for treatment of renal cell carcinoma, metastatic melanoma, and metastatic non-small cell lung cancer. While common side effects are known and well documented, encephalitis is documented as an extremely rare side effect. We present the case of an extremely rare side effect to a common chemotherapeutic agent. Hindawi 2018-01-17 /pmc/articles/PMC5822822/ /pubmed/29593922 http://dx.doi.org/10.1155/2018/4273231 Text en Copyright © 2018 Benjamin Chaucer et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Chaucer, Benjamin
Stone, Abriella
Demanes, Augustus
Seibert, Shawn M.
Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
title Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
title_full Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
title_fullStr Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
title_full_unstemmed Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
title_short Nivolumab-Induced Encephalitis in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
title_sort nivolumab-induced encephalitis in hereditary leiomyomatosis and renal cell cancer syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822822/
https://www.ncbi.nlm.nih.gov/pubmed/29593922
http://dx.doi.org/10.1155/2018/4273231
work_keys_str_mv AT chaucerbenjamin nivolumabinducedencephalitisinhereditaryleiomyomatosisandrenalcellcancersyndrome
AT stoneabriella nivolumabinducedencephalitisinhereditaryleiomyomatosisandrenalcellcancersyndrome
AT demanesaugustus nivolumabinducedencephalitisinhereditaryleiomyomatosisandrenalcellcancersyndrome
AT seibertshawnm nivolumabinducedencephalitisinhereditaryleiomyomatosisandrenalcellcancersyndrome

Ejemplares similares